Back to top

Glaukos (GKOS) Jumps: Stock Rises 7.2%

Read MoreHide Full Article

Glaukos Corporation (GKOS - Free Report) was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $38.13 to $45.36 in the past one-month time frame.

The company has seen one positive estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Glaukos. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Glaukos currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.  

Investors interested in the Medical - Instruments industry may consider Integer Holdings Corporation (ITGR - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is GKOS going up? Or down? Predict to see what others think:Up or Down

5 Companies Verge on Apple-Like Run

Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2018 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs. A bonus Zacks Special Report names this breakthrough and the 5 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains.

Click to see them right now >>
 




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Integer Holdings Corporation (ITGR) - free report >>

Glaukos Corporation (GKOS) - free report >>

More from Zacks Tale of the Tape

You May Like